期刊文献+

表皮葡萄球菌对氟喹诺酮类药物摄入的研究 被引量:1

Study on uptake of fluoroquinolones by Staphylococcus epidermidis
下载PDF
导出
摘要 目的 探讨耐药表皮葡萄球菌中是否存在主动外排系统,以揭示表皮葡萄球菌对氟喹诺酮类药物的耐药机制。方法 应用荧光法检测表皮葡萄球菌耐药株和敏感株对环丙沙星、司帕沙星的累积量以及加入利血平和碳酰氰间氯苯腙(CCCP)后对环丙沙星、司帕沙星累积量的变化情况。结果 表皮葡萄球菌临床株和敏感株中加入CCCP后菌体内环丙沙星、司帕沙星的累积量变化不大,而利血平可以使SR79菌体内环丙沙星的累积量显著上升。结论 表皮葡萄球菌中可能存在针对亲水性氟喹诺酮药物的主动外排系统。 Objective To explore whether active efflux system is present in Staphylococcus epidermidis in order to identify the resistance mechanism of S.epidermidis to antibiotics.Methods The accumulation of ciprofloxacin and sparfloxacin in S.epidermidis were measured by a fluorescence method and the influence of carbonyl cyanide m-chlorophenylhydrazone (CCCP) or reserpine was analyzed.Results Reserpine could dramatically increase the accumulation of ciprofloxacin in S.epidermidis SR79. However, CCCP had little effect on the accumulation of ciprofloxacin and sparfloxacin in clinical susceptible S. epidermidis isolates. Conclusions There may have an active efflux system targeting hydrophilic fluoroquinolones in S.epidermidis.
出处 《中国抗感染化疗杂志》 2005年第2期92-95,共4页 Chinese Journal of Infection and Chemotherapy
关键词 表皮葡萄球菌 氟喹诺酮类药物 主动外排系统 Staphylococcus epidermidis Fluoroquinolones Active efflux system
  • 相关文献

参考文献9

  • 1Takahata M, Yonezawa M, Matsubara N, et al. Antibacterial activity of quinolones against coagulase-negative staphylococci and the quinolone resistance-determining region of gyrA genes from six species[J]. J Antimicrob Chemother, 1997,40:383-386.
  • 2Hooper DC. Emerging mechanism of fluoroquinolone resistance [J]. Emerg Infect Dis, 2001,7: 337-341.
  • 3Denis A, Moreau NJ. Mechanisms of quinolone resistance in clinical isolate:accumulation of sparfloxacin and of fluoroquinolones of various hydrophicity,and analysis of membrane composition[J]. J Antimicrob Chemother, 1993,32:379-392.
  • 4何汉江,谭立志,陆春雪,姚艳冰.泌尿生殖道感染的葡萄球菌分布及对氟喹诺酮类药物的敏感性研究[J].实用预防医学,2003,10(6):915-917. 被引量:3
  • 5Takenouchi T,Tabat F, Iwata Y,et al. Hydrophilicity of quinolones is not an exclusive factor decreased activity in efflux-mediated resistant mutants of staphylococcus aureus[J]. Antimicrob Agents Chemother, 1996,40:1835-1842.
  • 6Fung-Tomc J,Minassian B,Kolek B,et al. In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacin [J]. J Antimicrob Chemother, 2000, 45: 437-446.
  • 7Denis A, Moreau NJ. Mechanisms of quinolone resistance in clinical isolate: accumulation of sparfloxacin and of fluoroquilones of various hydrophicity, and analysis of membrane composition[J]. J Antimicrob Chemother, 1993,32:379-392.
  • 8Markham PN. Inhibition of the emergence of ciprofloxacin resistance in Streptococcus pneumoniae by the multidrug efflux inhibitor reserpine[J]. Antimicrob Agents Chemother, 1999,43: 988-989.
  • 9Ross JI, Eady EA, Cove JH, et al. Identification of a chromosomally encoded ABC-transport system with which the staphylococcal erythromycin exporter MsrA may interact[J]. Gene,1995,153: 93-98.

二级参考文献1

  • 1张致平.喹诺酮类抗菌药研究的新进展(摘要)[A]..第四届全国喹诺酮类抗菌药科研与临床应用研讨会论文汇编:2000年8月[C].北京:四川成都:中国抗生素杂志社,2000.1-20.

共引文献2

同被引文献26

  • 1方治平,徐炜,刘小康,宋晓红.大肠杆菌体内氟喹诺酮类药物耐药机制的研究[J].四川大学学报(医学版),2005,36(1):86-89. 被引量:8
  • 2Bagel S, Hullen V, Wiedemann B, Heisig P. Impact of gyrA and parC mutations on quinolne resistance, doubling time, and supercoiling degree of Esherichia coli. Antimicrobial Agents and Chemotherapy, 1999, 43(4): 868-875.
  • 3Matrat S, Petrella S, Cambau E, Sougakoff W, Jarlier V, Aubry A. Expression and purification of an active form of the Mycobacterium leprae DNA gyrase and its inhibition by quinolones. Antimicrobial Agents and Chemotherapy, 2007, 51 (5): 1643-1648.
  • 4Sorlozano A, Gutierrez J, Jimenez A, Contribution of a new mutation in parE Luna J D, Martinez J L. to quinolone resistance in extended-spectrum-β-Lactamase-producing Escherichia coli isolates. Journal of Clinical Microbiology, 2007, 45 (8): 2740-2742.
  • 5Tran J H, Jacoby G A, Hooper D C. Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase. Antimicrobial Agents and Chemotherapy, 2005, 49(1): 118-125.
  • 6Yue L, Jiang H X, Liao X P, Liu J H, Li S J, Chen X Y, Chen C X, Lu D H, Liu Y H. Prevalence of plasmid-mediated qninolone resistance qnr genes in poultry and swine clinical isolates of Escherichia coli. Veterinary Microbiology, 2008, 132: 414-420.
  • 7Okusu H, Ma D, Nikaido H. AcrAB efllux pump plays a major role in the Antibiotic resistance phenotype of Escherichia coli multiple- antibiotic-resistance (Mar)mutants. Journal of Bacteriology, 1996, 178(1): 306-308.
  • 8Ghosh A S, Ahamed J, Chauhan K K, Kundu M. Involvement of an efflux system in high-level fluoroquinolone resistance of ShigeUa dysenteriae. Biocheical and Biophysical Research Communications, 1998, 242: 54-56.
  • 9Nikaido H. Multidrug efflux pumps of Gram-negative bacteria. Journal of Bacteriology, 1996, 178(20): 5853-5859.
  • 10Blanca M G, Teresa V, Jordi H B, Miguel V. The contribution of efflux pumps to quinolone resistance in Streptococcus pneumoniae clinical isolates. International Journal of Medical Microbiology, 2007, 297: 187-195.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部